Andrew J. Lees

129.0k citations
733 papers · 74.2k indexed · 26 hit papers · h-index 129

Impact in

  • Neurology top 0.01%
    • Parkinson's Disease Mechanisms and Treatments
    • Neurological disorders and treatments
    • Botulinum Toxin and Related Neurological Disorders
    • Neurological diseases and metabolism
    • Genetic Neurodegenerative Diseases
    • Nuclear Receptors and Signaling

Papers in

    • Parkinson's Disease Mechanisms and Treatments 519
    • Neurological disorders and treatments 356
    • Botulinum Toxin and Related Neurological Disorders 121
    • Neurological diseases and metabolism 96
    • Genetic Neurodegenerative Diseases 91

Andrew J. Lees

710 papers receiving 72.2k citations

Hit Papers

Medical, surgical, and physical treatments for Parkinson's disease 2024 · 88 citations
88198320261997201150010001.5k2.0k

Peers

Andrew J. Lees
Comparison fields: 5 of 205
  • Neurology 56.1k
  • Neurology 10.9k
  • Cellular and Molecular Neuroscience 21.1k
  • Cognitive Neuroscience 8.9k
  • Physiology 11.3k
Replace Anthony E. Lang with:
Anthony E. Lang Canada
Werner Poewe Austria
Glenda M. Halliday Australia
David J. Brooks United Kingdom
Joseph Jankovic United States
C. D. Marsden United Kingdom
Yves Agid France
Irene Litvan United States
K. A. Jellinger Austria
Heiko Braak Germany
Andrew J. Lees relative to Anthony E. Lang Canada Anthony E. Lang's profile →
Citations per field
00.5×1.5×
Anthony E. Lang · 1×
Citations per year

Countries citing papers authored by Andrew J. Lees

Since Specialization
Citations

This map shows the geographic impact of Andrew J. Lees's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew J. Lees with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew J. Lees more than expected).

Fields of papers citing papers by Andrew J. Lees

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew J. Lees. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew J. Lees. The network helps show where Andrew J. Lees may publish in the future.

Co-authors

The 25 scholars most cited alongside Andrew J. Lees, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Andrew J. Lees Line = papers co-authored together Andrew J. Lees links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 202152
2 202035
3 202026
4 201916
5 201916
6
Blood-based NfL
Hit paper breakdown →
2017356
7 20171
8 2013120
9
Impulsive compulsive behaviours in patients with Parkinson's disease treated with dopamine agonists
20121
10
Clinical Neuropathologic Correlation
20100
11 2008181
12 2007303
13
Anti-basal ganglia antibodies in patients with atypical dystonia and tics - A prospective study
20041
14
Clinical features of Progressive Supranuclear Palsy (PSP) in the United Kingdom
20012
15
An 18F dopa PET study of disease progression and subclinical nigrostriatal dysfunction in a Parkin kindred
20012
16
Panniculitis in association with apomorphine infusion.
199815
17
DOPAMINERGIC FUNCTION IN RELATIVES OF PARKINSONS-DISEASE PATIENTS - A CLINICAL AND PET STUDY
19951
18
Comparison of therapeutic effects of levodopa, levodopa and selegiline, and bromocriptine in patients with early, mild Parkinson’s disease: three year interim report
199344
19
DIFFERING PATTERNS OF STRIATAL F-18 DOPA UPTAKE IN PARKINSONS-DISEASE, MULTIPLE SYSTEM ATROPHY, AND PROGRESSIVE SUPRANUCLEAR PALSY
199029
20
Treatment of motor fluctuations in Parkinson’s disease with an oral sustained-release preparation of L-dopa: clinical and pharmacological observations.
19871

About Andrew J. Lees

Andrew J. Lees is a scholar working on Neurology, Neurology, Cellular and Molecular Neuroscience, Sensory Systems and Cognitive Neuroscience, having authored 733 papers that have together received 74.2k indexed citations. Recurring topics across this work include Parkinson's Disease Mechanisms and Treatments (519 papers), Neurological disorders and treatments (356 papers), Botulinum Toxin and Related Neurological Disorders (121 papers), Neurological diseases and metabolism (96 papers), Genetic Neurodegenerative Diseases (91 papers), Alzheimer's disease research and treatments (67 papers), Autism Spectrum Disorder Research (49 papers) and Obsessive-Compulsive Spectrum Disorders (48 papers). The work is most often cited by research in Neurology (56.1k citations), Neurology (10.9k citations), Cellular and Molecular Neuroscience (21.1k citations), Cognitive Neuroscience (8.9k citations) and Physiology (11.3k citations). Andrew J. Lees has collaborated with scholars based in United Kingdom, United States and Austria. Frequent co-authors include Andrew Hughes, S. E. Daniel, Linda Kilford, W R Gibb, Julian Fearnley, Tamás Révész, Susan E. Daniel, Niall Quinn, John Hardy and G M Stern. Their work appears in journals such as Movement Disorders, Journal of Neurology Neurosurgery & Psychiatry, Brain, Neurology and Annals of Neurology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026